Literature DB >> 7936150

Changes in the immunophenotype of recurrent pituitary adenomas.

T Mindermann1, K Kovacs, C B Wilson.   

Abstract

Only two cases have been reported of a pituitary adenoma that changed phenotype between its initial resection and recurrence. To determine the frequency of such cases among our patients, we examined the clinical course of these tumors and characterized any patterns. We reviewed the charts of 1023 patients with pituitary adenomas who underwent surgery between 1984 and 1992 at the University of California at San Francisco. Of the 65 patients (6.4%) who had operations for or clinical evidence of tumor recurrence, five (7.7%) had tumors that changed phenotype. The female-to-male ratio was 4:1, and age at the onset of symptoms was 33.2 +/- 15.3 years (mean +/- standard deviation). Changes occurred in hormone production and hormone release after 6.4 +/- 3.4 years. At some point, all five tumors were invasive and four were macroadenomas. Two patients had more than one operation for tumor recurrence; three had silent or symptomatic pituitary apoplexy; and three had undergone sellar irradiation before the changes in phenotype occurred. The behavior of these tumors therefore seems to be aggressive. We do not yet know whether phenotypic changes in pituitary adenomas have any treatment implications. Therefore, we advocate the complete immunostaining of primary and recurrent pituitary adenomas so that additional data about their clinical course can be collected.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936150     DOI: 10.1227/00006123-199407000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  8 in total

1.  The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.

Authors:  Alberto Righi; Marco Faustini-Fustini; Luca Morandi; Valentina Monti; Sofia Asioli; Diego Mazzatenta; Antonella Bacci; Maria Pia Foschini
Journal:  Endocrine       Date:  2016-08-04       Impact factor: 3.633

Review 2.  Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review.

Authors:  Fabienne Langlois; Dawn Shao Ting Lim; Chris G Yedinak; Isabelle Cetas; Shirley McCartney; Justin Cetas; Aclan Dogan; Maria Fleseriu
Journal:  Pituitary       Date:  2018-02       Impact factor: 4.107

3.  Pituitary adenoma with "honeycomb Golgi" appearance showing a phenotypic change at recurrence from clinically nonfunctioning to typical Cushing disease.

Authors:  Toshiaki Sano; Kalman Kovacs; Sylvia L Asa; Shozo Yamada; Naoko Sanno; Shunichi Yokoyama; Hiroshi Takami
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

4.  Genomic instability in pituitary adenomas.

Authors:  Janusz Szymas; Karsten Schluens; Wlodzimierz Liebert; Iver Petersen
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 5.  Modification of hormonal secretion in clinically silent pituitary adenomas.

Authors:  Tania Daems; Johan Verhelst; Alex Michotte; Pascale Abrams; Dirk De Ridder; Roger Abs
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

6.  Incidence, Pathology, and Recurrence of Pituitary Adenomas: Study of 647 Unselected Surgical Cases.

Authors:  Takahiko Terada; Kalman Kovacs; Lucia Stefaneanu; Eva Horvath
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

7.  Long term outcome following repeat transsphenoidal surgery for recurrent endocrine-inactive pituitary adenomas.

Authors:  Edward F Chang; Michael E Sughrue; Gabriel Zada; Charles B Wilson; Lewis S Blevins; Sandeep Kunwar
Journal:  Pituitary       Date:  2010-09       Impact factor: 4.107

8.  Change in the immunophenotype of a somatotroph adenoma resulting in gigantism.

Authors:  Jayesh P Thawani; Robert L Bailey; Carrie M Burns; John Y K Lee
Journal:  Surg Neurol Int       Date:  2014-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.